A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
Aztreonam has been studied across 9 research domains including 🫘 Kidney, ✨ Skin & Hair, 🫁 Respiratory, 🫁 Liver & Detox, 😴 Sleep. The primary research focus is 🫘 Kidney with 6% of studies addressing this area.
The following compounds share molecular targets with Aztreonam, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Aztreonam is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.